Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis
- PMID: 26403330
- PMCID: PMC11389156
- DOI: 10.1111/pbi.12479
Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis
Abstract
Although much explored, oral tolerance for treatment of autoimmune diseases still awaits the establishment of novel and effective vectors. We investigated whether the tolerogenic CTA1(R7K)-COL-DD fusion protein can be expressed in edible plants, to induce oral tolerance and protect against arthritis. The fusion protein was recombinantly expressed in Arabidopsis thaliana plants, which were fed to H-2(q) -restricted DBA/1 mice to assess the preventive effect on collagen-induced arthritis (CIA). The treatment resulted in fewer mice exhibiting disease and arthritis scores were significantly reduced. Immune suppression was evident in treated mice, and serum biomarkers for inflammation as well as anticollagen IgG responses were reduced. In spleen and draining lymph nodes, CD4(+) T-cell responses were reduced. Concomitant with a reduced effector T-cell activity with lower IFNγ, IL-13 and IL-17A production, we observed an increase in IL-10 production to recall antigen stimulation in vitro, suggesting reduced Th1, Th2 and Th17 activity subsequent to up-regulated IL-10 and regulatory T-cell (Treg) functions. This study shows that edible plants expressing a tolerogen were effective at stimulating CD4 T-cell tolerance and in protecting against CIA disease. Our study conveys optimism as to the potential of using edible plants for oral treatment of rheumatoid arthritis.
Keywords: CIA; FoxP3; IL-10; autoimmunity; edible plants; transgenic plants.
© 2015 Society for Experimental Biology, Association of Applied Biologists and John Wiley & Sons Ltd.
Figures





References
-
- Agren, L.C. , Ekman, L. , Lowenadler, B. and Lycke, N.Y. (1997) Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158, 3936–3946. - PubMed
-
- Arakawa, T. , Yu, J. , Chong, D.K. , Hough, J. , Engen, P.C. and Langridge, W.H. (1998) A plant‐based cholera toxin B subunit‐insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 16, 934–938. - PubMed
-
- Avesani, L. , Bortesi, L. , Santi, L. , Falorni, A. and Pezzotti, M. (2010) Plant‐made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we? Expert Rev. Vaccines 9, 957–969. - PubMed
-
- Barnett, M.L. , Combitchi, D. and Trentham, D.E. (1996) A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum. 39, 623–628. - PubMed
-
- Barnett, M.L. , Kremer, J.M. , St Clair, E.W. , Clegg, D.O. , Furst, D. , Weisman, M. , Fletcher, M.J. , Chasan‐Taber, S. , Finger, E. , Morales, A. , Le, C.H. and Trentham, D.E. (1998) Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double‐blind, placebo‐controlled trial. Arthritis Rheum. 41, 290–297. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials